Aims

Frontiers in Molecular Immunology (FMI) (ISSN: 2630-5429) is an open access, continuously published, international, refereed journal covering both basic immunology research and clinical applications, and provides the latest information and advancements in the immunological response of the host, both in vitro and in vivo.

Scope

FMI will accept high-profile submissions including but not limited to:  
• Molecular mechanisms of innate and adaptive immunity phenomena
• Molecular aspects of immune regulation
• Cell signalling and activation
• Cellular receptors and soluble mediators
• Immunogenomics, immunoproteomics and immunoglycomics
• Molecular (immuno) therapeutics
• Immunochemistry
• Impact of molecular changes at the tissue level